Betsy Johnson
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/32683_ejohnsn_0.jpg?itok=TzwZ0yH3)
Filters
Successful resolution of a media company's deduction for abandoned content
We defended the company against an IRS claim
Revolution Medicines $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Novavax $175.25 million convertible senior notes offering
The 5% convertible notes are due 2027
Flex $400 million notes offering
The investment-grade notes are due 2028
Wolfspeed $1.75 billion convertible senior notes offering
The 1.875% convertible senior notes are due 2029
UMB Financial $110 million notes offering
The fixed-to-fixed-rate investment-grade notes are due 2032
JPMorgan Chase medium-term note program
We advised JPMorgan Chase on the euro note program
Legend Biotech $403 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Revolution Medicines $264.5 million follow-on offering
The shares are listed on Nasdaq
Core Lab $60 million at-the-market offering
The company’s shares are traded on the NYSE and Euronext Amsterdam